BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 1, 2002
View Archived Issues
Bay-41-4109: a novel anti-HBV candidate
Read More
Cannabinoids may not improve symptoms of multiple sclerosis
Read More
Safe transition from i.v. epoprostenol to s.c. treprostinil in patients with PAH
Read More
Therapeutic angiogenic effects of rFGF-2 in patients with intermittent claudication
Read More
CVT-3146 set to enter phase III in 2003
Read More
Eligix CD8-SC Cell Separation System approved in E.U.
Read More
Fujisawa announces microbial research agreement with MerLion
Read More
Fujirebio acquires rights to ovarian tumor markers
Read More
Amersham Biosciences and Sloan-Kettering Institute collaborate to scan human genome
Read More
Immune Network and AbNovo to develop antibody-based therapeutics for viral diseases
Read More
Levaquin sNDA submitted for chronic bacterial prostatitis
Read More
Incara's IND for liver cell therapy approved
Read More
Zonagen awarded SBIR grant for Progenta in breast cancer
Read More
Bristol-Myers Squibb researchers identify CDK-inhibitory semicarbazides
Read More
Japanese, American and British scientists jointly describe new PI3K inhibitors
Read More
New CDK inhibitors in early development at BMS
Read More
Roche presents A2A antagonists with potential in depression and other disorders
Read More
Versicor and Biosearch Italia to merge
Read More
Aventis describes novel factor Xa/VIIa inhibitors and their use
Read More
Novel tryptase inhibitors emerge from Boehringer Ingelheim
Read More